These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2784879)

  • 1. BMA 031--a TCR-specific monoclonal antibody for clinical application.
    Kurrle R; Kanzy EJ; Racenberg J; Lang W; Seiler FR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1017-9. PubMed ID: 2784879
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological follow-up of renal allograft recipients treated with the BMA 031 (anti-TCR) monoclonal antibody.
    Chatenoud L; Ferran C; Legendre C; Kurrle R; Kreis H; Bach JF
    Transplant Proc; 1990 Aug; 22(4):1787-8. PubMed ID: 2117809
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of a monoclonal antibody against the T cell receptor for prophylactic immunosuppressive treatment after liver transplantation.
    Wonigeit K; Nashan B; Schwinzer R; Schlitt HJ; Kurrle R; Racenberg J; Seiler F; Ringe B; Pichlmayr R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2258-9. PubMed ID: 2652734
    [No Abstract]   [Full Text] [Related]  

  • 4. An overview of the use of the monoclonal antibody OKT3 in renal transplantation.
    Norman DJ
    Transplant Proc; 1988 Dec; 20(6):1248-52. PubMed ID: 2974204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of IL 2-driven proliferation of murine T lymphocyte clones by supraoptimal levels of immobilized anti-T cell receptor monoclonal antibody.
    Nau GJ; Moldwin RL; Lancki DW; Kim DK; Fitch FW
    J Immunol; 1987 Jul; 139(1):114-22. PubMed ID: 2953809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of in-vivo administration of a monoclonal antibody specific for the interleukin-2 receptor on the acute graft-versus-host reaction in mice.
    Volk HD; Brocke S; Osawa H; Diamantstein T
    Clin Exp Immunol; 1986 Oct; 66(1):126-31. PubMed ID: 3100116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulation of T cells by thymic hormone and monoclonal anti-T cell antibody.
    Bach JF; Dardenne M; Chatenoud L
    Transplant Proc; 1982 Sep; 14(3):509-12. PubMed ID: 6758237
    [No Abstract]   [Full Text] [Related]  

  • 8. Experience with a new monoclonal antibody in clinical kidney transplantation.
    Hillebrand G; Rothaug E; Hammer C; Illner WD; Schleibner S; Racenberg J; Gurland HJ; Land W
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1776-7. PubMed ID: 2652581
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization and expression of the human alpha beta T cell receptor by using a framework monoclonal antibody.
    Brenner MB; McLean J; Scheft H; Warnke RA; Jones N; Strominger JL
    J Immunol; 1987 Mar; 138(5):1502-9. PubMed ID: 3492555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses.
    Hirsch R; Eckhaus M; Auchincloss H; Sachs DH; Bluestone JA
    J Immunol; 1988 Jun; 140(11):3766-72. PubMed ID: 3286764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of a clonotypic antibody specific for the T cell receptor of an arthritogenic T cell clone--studies in adjuvant arthritis.
    van Tienhoven EA; Steenbakkers PG; Veenstra JG; van Kooten PJ; van der Cammen MJ; Broeren CP; van Eden W
    J Autoimmun; 2000 Aug; 15(1):1-8. PubMed ID: 10936022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in monoclonal antibodies in clinical transplantation.
    Cosimi AB
    Transplant Proc; 1994 Aug; 26(4):1943-4. PubMed ID: 7915057
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppression with monoclonal antibodies. A model to determine the rules for effective serotherapy.
    Cobbold SP; Thierfelder S; Waldmann H
    Mol Biol Med; 1983 Oct; 1(3):285-304. PubMed ID: 6209527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell receptor-based immunointervention in autoimmune diseases. Therapeutic use of monoclonal antibodies.
    Chatenoud L; Bach JF
    Immunol Ser; 1993; 59():101-16. PubMed ID: 7681694
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of monoclonal antibodies specific for the T cell receptor complex by Fc receptor-mediated CTL lysis.
    Leo O; Sachs DH; Samelson LE; Foo M; Quinones R; Gress R; Bluestone JA
    J Immunol; 1986 Dec; 137(12):3874-80. PubMed ID: 3097135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T lymphocytes expressing a defined T-cell antigen receptor family specifically kill the hybridoma that makes the anti-receptor monoclonal antibody.
    Boylston AW; May SJ
    Immunology; 1986 Nov; 59(3):383-7. PubMed ID: 3491783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific modulation of T cells and murine experimental allergic encephalomyelitis by monoclonal anti-idiotypic antibodies.
    Zhou SR; Whitaker JN
    J Immunol; 1993 Feb; 150(4):1629-42. PubMed ID: 7679432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monoclonal antibodies: therapeutic possibilities and limitations].
    Tax WJ; Capel PJ; Koene RA
    Tijdschr Kindergeneeskd; 1987 Feb; 55(1):1-9. PubMed ID: 3551184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations.
    Reinherz EL; Morimoto C; Fitzgerald KA; Hussey RE; Daley JF; Schlossman SF
    J Immunol; 1982 Jan; 128(1):463-8. PubMed ID: 6459376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymic selection process induced by hybrid antibodies.
    Zepp F; Staerz UD
    Nature; 1988 Dec; 336(6198):473-5. PubMed ID: 3057386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.